|Bid||1.7100 x 1400|
|Ask||1.7200 x 800|
|Day's Range||1.7000 - 1.7283|
|52 Week Range||1.4400 - 4.7500|
|Beta (5Y Monthly)||-1.81|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 03, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
vTv Therapeutics (VTVT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
vTv Therapeutics (VTVT) delivered earnings and revenue surprises of 85.71% and -99.10%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?